All In MedTech

Device Trial Radar · NCT04240587

Intranasal Neurostimulation for the Treatment of Neurosensory Abnormalities in CL Wearers (INTAC)

Last checked: Nov 20, 2026Latest source record: Nov 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Mar 23, 2020

Primary completion

Nov 3, 2021

Study completion Nov 3, 2021

Sponsor

Lead sponsor
Tufts Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
CooperVision, Inc.
First posted
Jan 27, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To find out if the use of an intranasal tear neurostimulator (ITN), may be useful in decreasing the pain symptoms felt by patients who experience contact lens discomfort.

Conditions

  • Contact Allergy
  • Neuropathic Pain

Interventions

  • TrueTear™ intranasal neurostimulator (ITN)Device

    The ITN delivers small electrical currents to the inner cavity of the nose, gently activating nerves that stimulate the body's natural tear production system. Those in the ITN "active" arm will receive the active tips which contain the current from the base to the nasociliary nerve. Those in the ITN "sham" arm will receive tips without the current.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the decrease in microneuromas by means of in vivo confocal microscopy (IVCM) among CLD subjects following treatmentTime frame: 3 months
  2. To measure the changes in the level of discomfort/pain after instillation of hyperosmolarity drops among CLD subjects following treatmentTime frame: 3 months
  3. To measure changes in Contact Lens Dry Eye Questionnaire (CLDEQ)-8 among CLD subjects using ITN.Time frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tufts Medical Center

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.